----
Forecast & Rating3 analysts currently cover Mesoblast, of which 3 give a positive rating. The average price target is $37.00, about 178.6% upside from the current price of $13.28. Coverage is limited, so the data is for reference only. Data as of Oct 16, 2026; this does not constitute investment advice.
Oct 16, 2026Price forecast
$37.00178.61%
Forecast & RatingBuy
3analysts
- Strong buy33.33%
- Buy66.67%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
- Strong buy
- 1
- Buy
- 2
- Hold
- 0
- Sell
- 0
- Strong sell
- 0
Target price forecast
Forecast dateOct 12, 2026
Forecast met21.2%
Stock price$13.28
Avg. target$35.0
High target$35
Low target$35
- Avg. target
- $35.0
- High target
- $35
- Low target
- $35
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.
